Abstract
The glomerulopathies are among the leading causes of end-stage renal disease and although numerous treatments are available, there is a growing need for early diagnosis. Then it is important the study of sensitive biomarkers and easy handling in clinical routine to detect the activity of these diseases, including episodes of reactivation. The plasma soluble urokinase plasminogen activator…